Browse
Submit Data
Databases
API
Help

Dataset Information

24 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1-Methyl-3-phenyl-imidazolidine-2-thione.

ABSTRACT: The asymmetric unit of the title cyclic thio-urea derivative, C10H12N2S, comprises two mol-ecules, each of which has a twist about the CH2-CH2 bond within the five-membered ring. The major difference between the independent mol-ecules is manifested in the relative orientations of the five- and six-membered rings [dihedral angles between the least-squares planes = 28.03?(11) and 41.54?(11)°]. A network of C-H?? inter-actions consolidates the three-dimensional crystal packing.

SUBMITTER: Nor NA

PROVIDER: S-EPMC3998490 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1-Methyl-3-phenyl-imidazolidine-2-thione.

Nor Nabihah Al Muna Mohd NA Abdullah Zanariah Z Ng Seik Weng SW Tiekink Edward R T ER

Acta crystallographica. Section E, Structure reports online 20140222 Pt 3

The asymmetric unit of the title cyclic thio-urea derivative, C10H12N2S, comprises two mol-ecules, each of which has a twist about the CH2-CH2 bond within the five-membered ring. The major difference between the independent mol-ecules is manifested in the relative orientations of the five- and six-membered rings [dihedral angles between the least-squares planes = 28.03 (11) and 41.54 (11)°]. A network of C-H⋯π inter-actions consolidates the three-dimensional crystal packing. ...[more]

PMID: 24765029

Similar Datasets

1,3-Bis(1-phenyl-eth-yl)imidazolidine-2-thione.

Project description:The complete molecule of the title compound, C(19)H(22)N(2)S, is generated by crystallographic twofold symmetry with the C=S group lying on the rotation axis. The imidazolidine ring adopts a flattened twist conformation. The dihedral angle between the asymmetric part of the imidazolidine-2-thione fragment and the benzene ring is 89.49?(17)°.

| S-EPMC3344125 | biostudies-literature

1,3-Dibenzyl-imidazolidine-2-thione.

Project description:In the title compound, C(17)H(18)N(2)S, the imidazolidine ring adopts a twisted conformation. In the crystal, mol-ecules are linked by slipped π-π inter-actions between the benzene rings of neighbouring mol-ecules [centroid-to-centroid distance = 3.903 (2) Å].

| S-EPMC3414971 | biostudies-literature

1-(4-Methoxy-phenyl-sulfon-yl)-5-methyl-5-phenyl-imidazolidine-2,4-dione.

Project description:The title compound, C(17)H(16)N(2)O(5)S, crystallized in the chiral monoclinic space group P2(1), with two enanti-omeric mol-ecules (A and B) in the asymmetric unit. It is composed of a methyl-imidazolidine-2,4-dione unit substituted with a phenyl group and a 4-methoxy-phenyl-sulfonyl group. The benzene ring mean planes are inclined to one another by 22.20?(14)° in mol-ecule A and by 15.82?(13)° in mol-ecule B. In the crystal structure, the A and B mol-ecules are linked by N-H?O hydrogen bonds, forming centrosymmetric dimers. A number of C-H?O inter-actions are also present in the crystal structure, leading to the formation of a three-dimensinoal network.

| S-EPMC2969567 | biostudies-literature

2,2'-[(4-Methyl-2-phenyl-imidazolidine-1,3-di-yl)bis-(methyl-ene)]diphenol.

Project description:The methyl-substituted imidazolidine ring of the title compound, C24H26N2O2, adopts an envelope conformation with the N atom adjacent to the methyl-ene group as the flap. The meth-yl-ethyl-ene fragment in this ring is disordered over two positions with an occupancy ratio of 0.899?(4):0.101?(4). The hy-droxy-benzyl groups are inclined at 71.57?(15) and 69.97?(19)° to the mean plane of major disorder component of the heterocyclic ring with an inter-planar angle between the two hy-droxy-benzyl groups of 66.00?(5)°. The phenyl substit-uent approaches a nearly perpendicular orientation relative to the mean plane of the imidazolidine ring, making a dihedral angle of 75.60?(12)°. This conformation is stabilized by two intra-molecular O-H?N bonds, which generate S(6) ring motifs.

| S-EPMC3793710 | biostudies-literature

Penta-carbon-yl(imidazolidine-2-thione-?S)tungsten(0).

Project description:In the title complex, [W(C(3)H(6)N(2)S)(CO)(5)], the W atom displays an octa-hedral coordination with five CO mol-ecules and an imidazolidine-2-thione mol-ecule. The W(CO)(5) unit is coordinated by the cyclic thione ligand through a W-S dative bond. The W-S and C-S bond lengths are 2.599?(2) and 1.711?(9)?Å, respectively. This last distance is significantly longer than that of free cyclic thio-ureas. The geometry of the title compound suggests sp(3)-hybridization of the S atom caused by the greatly polarized linkage W-S-C bond angle, which is close to tetra-hedral [109.50?(3)°]. In the crystal packing, N-H?O and N-H?S hydrogen-bonding inter-actions stabilize the structure and build up chains parallel to [101].

| S-EPMC2979448 | biostudies-literature

5-Ethyl-5-methyl-4-phenyl-5H-1,2,4-triazol-3(4H)-thione.

Project description:The five-membered ring of the title compound Δ(1)-1,2,4-triazoline-5-thione, C(11)H(13)N(3)S, is almost planar (r.m.s. deviation = 0.009 Å); the phenyl ring is aligned at 84.6 (2)° with respect to the five-membered ring. The crystal studied was a racemic twin with an approximate 20% minor twin component. Weak inter-molecular C-H⋯N hydrogen bonding is present in the crystal structure.

| S-EPMC3007980 | biostudies-literature

(5S,6R)-5-Methyl-6-phenyl-4-propyl-1,3,4-oxadiazinane-2-thione.

Project description:The title mol-ecule, C(13)H(18)N(2)OS, is an oxadiazinanthione derived from (1R,2S)-norephedrine. There are two molecules in the asymmetric. Both adopt roughly half-chair conformations; however, the 5-position carbon orients out of opposite faces of the oxadiazinanthiones plane in the two molecules. In the crystal structure, they are oriented as a dimer linked by a pair of N-H⋯S hydrogen bonds. The absolute configuration has been established from anomalous dispersion and confirms the known stereochemistry based on the synthetic procedure.

| S-EPMC2969751 | biostudies-literature

1-[5-(Dimethyl-amino)-1-naphthylsulfon-yl]imidazolidine-2-thione.

Project description:In the title mol-ecule, C(15)H(17)N(3)O(2)S(2), the dihedral angle between the naphthalene ring system and the imidazole ring is 89.63?(2)°. The crystal structure is stablized by weak inter-molecuar C-H?? and N-H?? inter-actions.

| S-EPMC3007268 | biostudies-literature

1,3-Bis(1-cyclo-hexyl-eth-yl)imidazolidine-2-thione.

Project description:The complete mol-ecule of the title compound, C(19)H(34)N(2)S, is generated by crystallographic twofold symmetry, with the C=S group lying on the rotation axis. A short C-H⋯S contact occurs in the mol-ecule. The five-membered ring is twisted and the cyclo-hexyl ring adopts a chair conformation. The dihedral angle between the mean plane of the five-membered ring and the basal plane of the cyclo-hexyl ring is 75.32 (13)°.

| S-EPMC3295511 | biostudies-literature

1-(4-Chloro-phenyl-sulfon-yl)-5-(4-fluoro-phen-yl)-5-methyl-imidazolidine-2,4-dione.

Project description:The title compound, C(16)H(12)ClFN(2)O(4)S, crystallizes with two independent mol-ecules (A and B) in the asymmetric unit. The two mol-ecules are U-shaped with similar geometries and conformations. The mean planes through the benzene rings are inclined to one another by 6.07 (8)° in mol-ecule A and 8.67 (8)° in mol-ecule B. They are separated with a centroid-centroid distance of 3.9096 (10) Å in mol-ecule A and 3.9118 (10) Å in mol-ecule B. Mol-ecules A and B lie adjacent to one another, with a centroid-centroid distance of 3.7592 (10) Å between the fluoro-phenyl ring of mol-ecule A and the chloro-phenyl-sulfonyl ring of mol-ecule B and with a dihedral angle of 5.75 (8)° between the ring planes. In the crystal structure, A and B mol-ecules are linked by N-H⋯O hydrogen bonds, forming centrosymmetric dimers. These dimers stack along the [110] direction and are linked by C-H⋯O and C-H⋯F inter-actions. There are also some short halide⋯halide contacts [Cl⋯F = 3.0499 (14) and 3.1224 (13) Å, and F⋯F = 3.0612 (17) Å].

| S-EPMC2968985 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data